Substitution of the carboxyl-terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout mice.

類似資料

• Macrophage apoAI protects against dyslipidemia-induced dermatitis and atherosclerosis without affecting HDL
  著者:: Tavori, Hagai, 等
  出版事項: (2015)
• Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis
  著者:: Valanti, Eftaxia-Konstantina, 等
  出版事項: (2018)
• Sialidase down-regulation reduces non-HDL cholesterol, inhibits leukocyte transmigration, and attenuates atherosclerosis in ApoE knockout mice
  著者:: White, Elizabeth J., 等
  出版事項: (2018)
• HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis
  著者:: Chyu, Kuang-Yuh, 等
  出版事項: (2015)
• HDL-apoA-I Exchange: Rapid Detection and Association with Atherosclerosis
  著者:: Borja, Mark S., 等
  出版事項: (2013)